Updates

October 15, 2020October 15, 2020
4 Challenges Teens With Juvenile Arthritis May Face

I’m probably in the minority, but I loved high school. Those four years were a blast! Some of my favorite memories include participating in National Honors ... Read more
October 15, 2020October 15, 2020
Gene Variants May Predict Adverse MTX Treatment Outcome in JIA Patients

Variations in single nucleotides — the building blocks of DNA — in two genes may help predict the safety and efficacy of methotrexate (MTX) ... Read more
October 8, 2020October 6, 2020
JA-friendly Alternatives to Halloween Activities

Despite being the biggest scaredy-cat who ever lived, I enjoyed some Halloween festivities as a child. While I avoided haunted houses and scary movies ... Read more
October 8, 2020October 8, 2020
Genetic Score Helps Diagnose JIA, Study Suggests

A genomic risk score (GRS), based on DNA analysis, may reliably help diagnose children with juvenile idiopathic arthritis (JIA) and its various subtypes, a ... Read more
October 2, 2020October 2, 2020
FDA Approves Janssen’s Simponi Aria for Juvenile Arthritis Indications

The U.S. Food and Drug Administration (FDA) has approved Janssen‘s Simponi Aria (golimumab) for the treatment of active polyarticular juvenile idiopathic arthritis (pJIA) and juvenile psoriatic ... Read more

Subscribe to our mailing list

Get regular updates delivered to your email box.

Thanks! Please check your email for a confirmation email.

September 22, 2017September 22, 2017

Systemic Arthritis and Prolonged Corticosteroid Use Associated with Growth Impairment in Juvenile Idiopathic Arthritis

News

A recent study showed that children with juvenile idiopathic arthritis (JIA) now have similar growth and weight gain as children in the general population. Nonetheless, about 1 in 10 JIA children with systemic arthritis, uncontrolled disease, or prolonged use of ... Read more

Updates

4 Challenges Teens With Juvenile Arthritis May Face

Gene Variants May Predict Adverse MTX Treatment Outcome in JIA Patients

JA-friendly Alternatives to Halloween Activities

Genetic Score Helps Diagnose JIA, Study Suggests

FDA Approves Janssen’s Simponi Aria for Juvenile Arthritis Indications

Subscribe to our mailing list

Helping Kids With JA Cope With Medical Fears

FDA Approves Xeljanz for Polyarticular JIA

Parenting a Child With Juvenile Arthritis Requires Balance

Lower Doses of Ilaris Can Maintain Clinical Remission in Systemic-onset JIA, Trial Shows

Brenzys, Biosimilar to Enbrel, Approved to Treat JIA in Canada

Biologics as Initial sJIA Therapy Rising in US, But Glucocorticoids Still in Wide Use

How to Stay Positive When Others Share Negative JA Experiences

Injuries Can Be a Big Deal With Juvenile Arthritis

Nepexto, Biosimilar of Enbrel, Now Available in Germany

Getting a Diagnosis Sometimes Brings Considerable Relief

Humira Shows Long-term Efficacy and Safety in Polyarticular JIA, Phase 3 Trial Reports

5 Overlapping Symptoms of JA and Depression

JIA Type and Medication Use Affect Longevity of Joint Implants, Study Reports

4 Ways to Ease the Pain of Biologic Injections

Sometimes Kids With Juvenile Arthritis Need Encouragement

sJIA Patients May Benefit More From Biologics Than Non-systemic, Review Finds

For a Child Newly Diagnosed With JA, There’s Hope for the Future

Fundraisers and Fun Mark July, Juvenile Arthritis Awareness Month

When Juvenile Arthritis Becomes the Butt of the Joke

Hulio, Biosimilar of Humira, Wins FDA Approval for JIA, But Not Available Until 2023

‘Inside Out’ Helps Kids With JA Talk About Their Feelings

Is Remote Learning the Best Option for Kids with JA?

MEFV Gene Mutation May Be Risk Factor for sJIA, Study Suggests

Systemic Arthritis and Prolonged Corticosteroid Use Associated with Growth Impairment in Juvenile Idiopathic Arthritis

Pin It on Pinterest

4 Challenges Teens With Juvenile Arthritis May Face

Gene Variants May Predict Adverse MTX Treatment Outcome in JIA Patients

JA-friendly Alternatives to Halloween Activities

Genetic Score Helps Diagnose JIA, Study Suggests

FDA Approves Janssen’s Simponi Aria for Juvenile Arthritis Indications

Subscribe to our mailing list

Helping Kids With JA Cope With Medical Fears

FDA Approves Xeljanz for Polyarticular JIA

Parenting a Child With Juvenile Arthritis Requires Balance

Lower Doses of Ilaris Can Maintain Clinical Remission in Systemic-onset JIA, Trial Shows

Overcoming Loneliness Caused by Juvenile Arthritis

Brenzys, Biosimilar to Enbrel, Approved to Treat JIA in Canada

Biologics as Initial sJIA Therapy Rising in US, But Glucocorticoids Still in Wide Use

How to Stay Positive When Others Share Negative JA Experiences

Injuries Can Be a Big Deal With Juvenile Arthritis

Nepexto, Biosimilar of Enbrel, Now Available in Germany

Getting a Diagnosis Sometimes Brings Considerable Relief

Humira Shows Long-term Efficacy and Safety in Polyarticular JIA, Phase 3 Trial Reports

5 Overlapping Symptoms of JA and Depression

JIA Type and Medication Use Affect Longevity of Joint Implants, Study Reports

4 Ways to Ease the Pain of Biologic Injections

Sometimes Kids With Juvenile Arthritis Need Encouragement

sJIA Patients May Benefit More From Biologics Than Non-systemic, Review Finds

For a Child Newly Diagnosed With JA, There’s Hope for the Future

Fundraisers and Fun Mark July, Juvenile Arthritis Awareness Month

When Juvenile Arthritis Becomes the Butt of the Joke

Hulio, Biosimilar of Humira, Wins FDA Approval for JIA, But Not Available Until 2023

‘Inside Out’ Helps Kids With JA Talk About Their Feelings

Is Remote Learning the Best Option for Kids with JA?

How to Thoughtfully Raise Awareness About Juvenile Arthritis

MEFV Gene Mutation May Be Risk Factor for sJIA, Study Suggests

Pin It on Pinterest